AOC3 and obesity disorder: Circulating activity of AOC3/SSAO increase during biological stress in multiple pathologic states including HF, obesity, atherosclerosis, diabetes and inflammatory liver diseases, and are an independent marker of mortality in patients with chronic HF44–48.